Treatments

A Comprehensive Look at Emerging Myeloma Treatments and Testing

In part one of our myeloma town meeting, myeloma experts break down the latest treatment research and testing tools. Watch the discussion led by patient advocate Jack Aiello.

Krina Patel, MD, MSc, Elisabet Manasanch, MD, Sagar Lonial, MD, FACP, Pei Lin, MD, Thomas Verm, LMSW

What Does the ENDURANCE Trial Mean for Myeloma Patients?

What is the ENDURANCE trial and what does it mean for myeloma patients? A savvy patient advocate walks us through the latest information on this clinical trial.

Jack Aiello, James Omel, MD

Latest News

Promising Treatments For Relapsed Myeloma

Andrew Schorr, Paul Richardson, MD

Treating Myeloma in Patients with Renal Insufficiency

Jack Aiello, Maddie Hunter

What Does the StaMINA Trial Mean for Myeloma Patients?

Jack Aiello, Cynthia Chmielewski

Approval of Myeloma Drug Improves Patients’ Prospects

Creating Your Myeloma Treatment Path and Factors to Consider

Shebli Atrash, MD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD, FACP, MRCP, FRCPath, Maddie Hunter

Treatment Strategies for Relapsed Myeloma

Jennifer Ahlstrom, Faith Davies, MD, MBBCh, MRCP, FRCPath, Nina Shah, MD, Larry Anderson, Jr., MD, PhD

What's Important for Patients With Myeloma?

Andrew Schorr, Jack Aiello

The Promise of CRISPR

Drugs Approved for Other Cancers Overcome Resistance in Myeloma

James Berenson, MD, Andrew Schorr

Managing the Side Effects of Selinexor

James Berenson, MD, Andrew Schorr

What Medicines Are Used to Protect Bones in Myeloma Patients?

Krina Patel, MD, MSc, Sagar Lonial, MD, FACP, Jack Aiello

Which Myeloma Patients Could Benefit From Anti-BCMA Trials?

Sikander Ailawadhi, MD, Esther Schorr